InvestorsHub Logo
Followers 4
Posts 222
Boards Moderated 0
Alias Born 12/20/2011

Re: frrol post# 202415

Friday, 11/03/2017 1:02:36 PM

Friday, November 03, 2017 1:02:36 PM

Post# of 403033
K is a potential block buster, and if the K-OC trial proves efficacious even though the trial is small, women diagnosed with Stage IV ovarian cancer have a five-year survival rate of only 17% it's off to the races.
With all of this potential the anticipation is at a fever pitch.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News